Inspira Technologies宣布Hyla血液传感器达到97.3%准确率,正推进FDA许可申请

美股速递
Sep 11, 2025

Inspira Technologies Oxy B.H.N. Ltd.宣布,其Hyla血液传感器在测试中实现了97.3%的准确率,公司正朝着向美国食品药品监督管理局(FDA)提交许可申请的目标稳步推进。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10